drugset / Trial / NCT01643226

Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus

NCT01643226

Phase 3 Completed 230 enrolled Glaukos Corporation
RandomizedParallel-groupSingle-blindTreatment

Summary

The objectives of this study are to evaluate the safety and efficacy of corneal collagen cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System as compared to placebo in impeding the progression of, and/or reducing, maximum corneal curvature.

Timeline

Start
2012-07
Primary completion
2015-07
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Riboflavin Other / unclassified 0.12 %

Indications